[{"AccountsPayableCurrent_0_Q2_USD":222000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8900000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":33000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-2975000.0,"RealizedInvestmentGainsLosses_2_Q2_USD":253000.0,"MarketableSecuritiesCurrent_0_Q2_USD":114302000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":9989000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":6863000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":17144000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":8900000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-9000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":78000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-932000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":486062000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":823000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":318000.0,"StockRepurchasedDuringPeriodShares_2_Q2_shares":3839251.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":12.31,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":2791102.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":154000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":679000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":309000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":1072000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-120635000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-65798000.0,"DebtInstrumentConvertibleBeneficialConversionFeature_1_Q2_USD":109000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":874863000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":529000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-982000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":994000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":117094000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":594000.0,"AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_0_Q2_USD":100376000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":17805000.0,"ResearchAndDevelopmentInProcess_1_Q2_USD":15000000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":80098000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":38684000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":73777000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":10292000.0,"OperatingLeasePayments_2_Q2_USD":1500000.0,"OperatingLeasePayments_1_Q2_USD":800000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":7856000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3245000.0,"OperatingLeaseLiability_0_Q2_USD":11101000.0,"OperatingLeaseCost_2_Q2_USD":1570000.0,"OperatingLeaseCost_1_Q2_USD":817000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":113708000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1397000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3923000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3220000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1694000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":1746000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":12498000.0,"LesseeOperatingLeaseDiscountRate_0_Q2_pure":0.07,"LeaseCost_2_Q2_USD":1608000.0,"LeaseCost_1_Q2_USD":833000.0,"FairValueEquityLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueEquityLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-16000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":350989000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":114302000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1915000.0,"ShortTermLeaseCost_1_Q2_USD":16000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":22225000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":1778000.0,"StockholdersEquity_0_Q2_USD":420324000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-455114000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":5757000.0,"ProfitLoss_2_Q2_USD":-120944000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":117094000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8036000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":954000.0,"NetIncomeLoss_2_Q2_USD":-120944000.0,"NetIncomeLoss_1_Q2_USD":-66870000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-94694000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":134283000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":311400000.0,"LiabilitiesCurrent_0_Q2_USD":27544000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":66599915.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":625076000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":548000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-727000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":22403000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":11655000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.88,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.0,"CommonStockValue_0_Q2_USD":8000.0,"CommonStockSharesOutstanding_0_Q2_shares":71972610.0,"CommonStockSharesIssued_0_Q2_shares":75811862.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":486062000.0,"AssetsCurrent_0_Q2_USD":608400000.0,"Assets_0_Q2_USD":625076000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":567000.0,"Liabilities_0_Q2_USD":204752000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1911222.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":64245119.0,"CommitmentsAndContingencies_0_Q2_USD":null,"OtherAssetsNoncurrent_0_Q2_USD":627000.0,"OperatingLeasesRentExpenseNet_2_Q2_USD":1800000.0,"OperatingLeasesRentExpenseNet_1_Q2_USD":800000.0,"NonoperatingIncomeExpense_2_Q2_USD":-638000.0,"NonoperatingIncomeExpense_1_Q2_USD":-1531000.0,"LongTermDebtNoncurrent_0_Q2_USD":28637000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":57000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":14.3,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.49,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":13.88,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":9863703.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":12.96,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":541572.0,"AccruedLiabilitiesCurrent_0_Q2_USD":14167000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":2187000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1893000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":139000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":44007.0,"ShareBasedCompensation_2_Q2_USD":17144000.0,"ProceedsFromConvertibleDebt_2_Q2_USD":193596000.0,"OperatingIncomeLoss_2_Q2_USD":-120306000.0,"OperatingIncomeLoss_1_Q2_USD":-65339000.0,"OperatingExpenses_2_Q2_USD":120306000.0,"OperatingExpenses_1_Q2_USD":65339000.0,"InterestPayableCurrent_0_Q2_USD":1343000.0,"InterestPaidNet_2_Q2_USD":1243000.0,"CommonStockSharesAuthorized_0_Q2_shares":700000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PropertyPlantAndEquipmentGross_0_Q2_USD":7650000.0,"ShortTermLeaseCost_2_Q2_USD":38000.0,"Ticker":"GOSS","CIK":"1728117","name":"GOSSAMER BIO, INC.","OfficialName":"Gossamer Bio Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"635524809.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200811"}]